Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.-论文-万方医学网

作者： Joon Hee,Kang ^[1] ; Seon-Hyeong,Lee ^[1] ; Jae-Seon,Lee ^[1] ; Boas,Nam ^[2] ; Tae Wha,Seong ^[1] ; Jaekyoung,Son ^[2] ; Hyonchol,Jang ^[1] ; Kyeong Man,Hong ^[1] ; Cheolju,Lee ^[3] ; Soo-Youl,Kim ^[4]

作者单位： Cancer Cell and Molecular Biology Branch, Research Institute, National Cancer Center, Goyang, Gyeonggi-do 410-769, Republic of Korea. ^[1] Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea. ^[2] Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 136-791, Republic of Korea. ^[3] Department of Biological Chemistry, University of Science and Technology, Daejeon 305-333, Republic of Korea. ^[4]

主题词动作电位(Action Potentials);腺苷三磷酸(Adenosine Triphosphate);醛脱氢酶(Aldehyde Dehydrogenase);动物(Animals);天冬氨酸(Aspartic Acid);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);细胞系, 肿瘤(Cell Line, Tumor);胞质溶胶(Cytosol);女(雌)性(Female);棉酚(Gossypol);人类(Humans);肺肿瘤(Lung Neoplasms);苹果酸盐(Malates);膜电位, 线粒体(Membrane Potential, Mitochondrial);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);线粒体(Mitochondria);NAD(NAD);NADP(NADP);肿瘤移植(Neoplasm Transplantation);氧化磷酸化(Oxidative Phosphorylation);作用于CH-NH族供体的氧化还原酶类(Oxidoreductases Acting on CH-NH Group Donors);苯乙双胍(Phenformin);RNA, 小分子干扰(RNA, Small Interfering)

DOI 10.18632/oncotarget.10354

PMID 27384481

发布时间 2019-12-10

检索历史清除

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

Oncotarget

相似文献

Oncotarget

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

Oncotarget

相似文献

Oncotarget

相关期刊

检索历史清除